Timothy P Grady DO
Interventional Cardiology, Nuclear Cardiology, Peripheral Endovascular Interventional Cardiology, Cardiac Critical Care
Physician
Join to View Full Profile
500 Wind Ridge DrWausau, WI 54401
Phone+1 715-847-2611
Fax+1 715-847-2465
Dr. Grady is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Galachia medical groupInterventional fellowship cardiology , 1993 - 1994
USA HealthFellowship, Cardiovascular Disease, 1990 - 1993
University of Missouri-ColumbiaResidency, Internal Medicine, 1987 - 1990
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 1986
Certifications & Licensure
WI State License 1997 - 2025
MI State License 2008 - 2024
TN State License 1994 - 2022
KS State License 1993 - 2017
AL State License 1990 - 1993
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Heart/Stroke Recognition Program National Committee for Quality Assurance, 2009-2012
- Fellow (FACC) American College of Cardiology
- Cardiac Care Recognition Health Care Incentives Improvement Institute
Publications & Presentations
PubMed
- Clinical outcomes following implantation of the ION™ paclitaxel-eluting platinum chromium coronary stent in routine clinical practice: Results of the ION U.S. post-app...Louis Cannon, Carey Kimmelstiel, Anthony White, R J Hill, Timothy Grady
Catheterization and Cardiovascular Interventions. 2019-09-01 - 39 citationsClinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY StentsDean J. Kereiakes, Stephan Windecker, R. Lee Jobe, Shamir R. Mehta, Ian J. Sarembock
Circulation. Cardiovascular Interventions. 2019-08-27 - 182 citationsEfficacy and Safety of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent The EVOLVE II Randomized TrialDean J. Kereiakes, Ian T Meredith, Stephan Windecker, R. Lee Jobe, Shamir R. Mehta
Circulation. Cardiovascular Interventions. 2015-04-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
